Latest Regulatory News

Everest Metals Corporation has revealed a promising 1.1km gold anomaly at its Revere project, completed a key rubidium extraction study at Mt Edon, and is poised to start mining at Mt Dimer by year-end.

PainChek Limited has secured a A$7.5 million placement to fuel its international expansion, with US FDA clearance for its adult pain assessment app expected imminently. The company reports strong license growth and a 26% revenue increase year-on-year.

Peel Mining Limited has completed key drilling and commenced metallurgical testing at Wagga Tank, while advancing exploration and joint venture activities at Curnamona, maintaining a solid cash position of $1.4 million.

Berkeley Energia advances critical minerals exploration with promising lithium and rubidium findings at its Conchas Project, while escalating a $1 billion arbitration against Spain over uranium project permitting. Political shifts in Spain’s nuclear policy add a new dimension to the company’s strategic outlook.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir ahead of schedule, setting sights on expedited FDA approval leveraging the Animal Rule.

Estrella Resources has made significant strides in its maiden manganese drilling campaign in Timor-Leste, confirming high-grade mineralisation and advancing a major limestone marketing agreement with an Indonesian partner.

Juno Minerals has agreed to sell its Mount Mason DSO Hematite Project for A$6 million cash plus a 2% royalty, while maintaining focus on its flagship Mount Ida Magnetite Project. The transaction strengthens Juno’s cash position and sets the stage for renewed development efforts.

Battery Age Minerals has initiated its maiden drilling campaign at the Bleiberg Zinc-Germanium Project following regulatory approval, while advancing exploration at El Aguila with a $3 million capital raise backing its growth.

FireFly Metals reports exceptional drilling results at its Green Bay Copper-Gold Project, extending mineralisation well beyond current resources. Backed by a substantial A$145 million capital raise, the company is poised for a resource update and advancing mining studies.

Black Dragon Gold progresses its Salave Gold Project’s strategic investment application amid positive community support and reports a stable cash position at quarter-end.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology candidate, completed FDA IND transfer, and plans to launch phase II trials in 2026. The company also reported a solid cash position and issued loyalty options to shareholders.

Peppermint Innovation Ltd reported robust growth in registered users, loan approvals, and transaction volumes in its June 2025 quarter, alongside strategic partnerships and key platform upgrades aimed at expanding financial inclusion in the Philippines.